Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Clinical trial NCT05327114 · RECRUITING
Trial details
- NCT number
- NCT05327114
- Sponsor
- Janssen Research & Development, LLC
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-23
- Primary completion
- 2027-05-14
- Enrollment
- 201
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.